☆ 4.3 Article

The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions

INTERNATIONAL JOURNAL OF DRUG POLICY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Substance Abuse

Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020

Kristy M. Scarfone et al.

Summary: Toronto's drug checking service has identified a range of substances containing high-potency opioids, stimulants, benzodiazepine-type drugs, and a synthetic cannabinoid. The information provided by this service can inform evidence-informed overdose prevention efforts.

HARM REDUCTION JOURNAL (2022)

添加到收藏夹

Article Substance Abuse

Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis

Joseph Friedman et al.

Summary: This study found that xylazine is increasingly present in overdose deaths in the US, primarily linked to illicitly-manufactured fentanyls. The highest prevalence was observed in Philadelphia, and individuals who inject drugs described xylazine as an adulterant that lengthens the duration of fentanyl injections but also increases the risk of soft tissue infection and naloxone-resistant overdose.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Article Substance Abuse

Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021

Joseph J. Palamar et al.

Summary: The prevalence of fentanyl-laced counterfeit prescription pills in the United States is increasing, with a significant rise in the number of fentanyl-containing powder and pill seizures. The proportion of pill seizures to total seizures has more than doubled, indicating a shift towards pill form exposure to fentanyl.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Article Substance Abuse

Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness

Thomas D. Brothers et al.

Summary: During the COVID-19 outbreak in Halifax, a healthcare team provided emergency safe supply and managed alcohol programs to residents in congregate shelters. The program showed high rates of successful isolation completion and low incidence of adverse events.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Review Toxicology

Non-fentanyl-derived synthetic opioids emerging during recent years

Koutaro Hasegawa et al.

Summary: Contrary to expectations, the number of synthetic opioid products and poisoning cases in the USA has increased by about 30% since China declared the prohibition of licit fentanyl analogue production. In recent years, various benzimidazole synthetic opioids have revived on the illicit drug market.

FORENSIC TOXICOLOGY (2022)

添加到收藏夹

Article Substance Abuse

A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept

T. MacDonald et al.

Summary: Low-dose subcutaneous flumazenil may help reduce BZD use and withdrawal symptoms in participants taking daily diazepam equivalent doses greater than or equal to the therapeutic maximum (>30 mg) by reducing the need for diazepam.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Article Substance Abuse

Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: Evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada

Erica McAdam et al.

Summary: The study found that over a third of drug users perceived a decline in drug quality during the COVID-19 pandemic, and these individuals were more likely to report recent non-fatal overdose, frequent injection drug use, and stimulant use.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Article Medicine, General & Internal

Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario

Tara Gomes et al.

Summary: The safer opioid supply (SOS) program launched by London InterCommunity Health Centre (LIHC) has been shown to reduce healthcare utilization and costs for patients with opioid use disorder (OUD). The program effectively decreased emergency department visits, hospital admissions, and healthcare costs not related to primary care or outpatient medications. These findings suggest that SOS programs play a crucial role in expanding treatment and harm-reduction options for individuals at high risk of drug poisoning.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)

添加到收藏夹

Article Substance Abuse

Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study

Mohammad Karamouzian et al.

Summary: The delisting of OxyContin did not reduce the use of unregulated opioids among people who use opioids. Instead, there was a shift in substance use patterns among this population post-intervention.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

添加到收藏夹

Article Substance Abuse

Drug checking use and interest among people who inject drugs in Toronto, Canada

Indhu Rammohan et al.

Summary: This study analyzed questionnaire data and found that although recent informal DCS use was not frequent, there was a high willingness to use a formal DCS. Laboratory-based DCS may play an important role in mitigating overdose risk, but barriers to access and reduced interest need to be addressed to ensure equitable use among high-risk individuals.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

添加到收藏夹

Review Clinical Neurology

Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects

Amber N. Edinoff et al.

Summary: Designer benzodiazepines, such as flubromazolam, clonazolam, deschloroetizolam, and meclonazepam, have gained popularity in recent years and have become readily available on the internet drug market. These drugs provide strong sedation effects but also come with numerous risks and side effects.

NEUROLOGY INTERNATIONAL (2022)

添加到收藏夹

Article Substance Abuse

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

Farihah Ali et al.

Summary: The study showed that COVID-19 has negatively impacted substance supply and use among PWUD, leading to increased consumption and substitution for toxic substances, which in turn increased the risk of related harms. These findings highlight the need for improved support services, safe supply programs, and other measures to mitigate risks for PWUD when using substances.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

添加到收藏夹

Article Substance Abuse

An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods

Matthew K. Laing et al.

Summary: The study revealed NPS benzodiazepine adulteration in an unregulated drug supply sample, highlighting new risks in the ongoing synthetic opioid epidemic. Point-of-care detection methods showed significant false positive and false negative rates, suggesting cautious use of combined methods with confirmatory drug checking for early detection and monitoring of unregulated drug markets.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

添加到收藏夹

Article Substance Abuse

Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study

Tara Beaulieu et al.

Summary: Stimulant samples were more likely to be checked pre-consumption compared to opioid samples, especially in regions outside the epicenter of the province's drug scene.

HARM REDUCTION JOURNAL (2021)

添加到收藏夹

Reprint Surgery

Trends in nonfatal and fatal overdoses involving benzodiazepines-38 states and the District of Columbia, 2019-2020

Stephen Liu et al.

Summary: This article discusses the significant rise in benzodiazepine-involved overdose deaths, particularly those related to illicit benzodiazepines, between 2019 and 2020. The majority of cases also involved opioids, especially illicitly manufactured fentanyls, and this increase in benzodiazepine-involved overdose deaths may have impacted the donor pool.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Psychiatry

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach

Valeria Catalani et al.

Summary: This research utilized a web crawler and social media to investigate emerging NPS discussed during the pandemic, revealing potential disruptions in drug markets and the need to enhance monitoring and control measures.

FRONTIERS IN PSYCHIATRY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Towards cross-Canada monitoring of the unregulated street drug supply

Emily Biggar et al.

Summary: This study developed a low-barrier system for monitoring the contents of drugs in the unregulated street supply and compared drug use trends across regions. The results showed variations in reported and detected substance use across different areas, highlighting the need for standardization and expansion of the monitoring system.

BMC PUBLIC HEALTH (2021)

添加到收藏夹

Article Clinical Neurology

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records

Sheryl Ker et al.

Summary: The study examined attrition patterns among opioid use disorder (OUD) patients treated with buprenorphine (BUP) in various settings, showing higher retention rates for patients in outpatient settings, particularly among females, whites, milder cases, and those not using non-psychotropic medications. Predictive modeling revealed that factors such as higher global assessment of functioning, lower OUD severity, higher initial BUP dose, outpatient BUP initiation, and fewer psychotropic medications were associated with longer retentions, with the model accurately identifying 75.2% of patients who left treatment within three months with a precision of 90.5%.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

The Emerging Role of Toxic Adulterants in Street Drugs in the US Illicit Opioid Crisis

Vanila M. Singh et al.

PUBLIC HEALTH REPORTS (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing-exploratory analyses from Canada

Benedikt Fischer et al.

BMC PUBLIC HEALTH (2020)

添加到收藏夹

Review Neurosciences

'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports

Laura Orsolini et al.

CURRENT NEUROPHARMACOLOGY (2020)

添加到收藏夹

Article Health Care Sciences & Services

A decade of extreme oscillations in opioid control and availability: implications for public health in a Canadian setting

Benedikt Fischer et al.

JOURNAL OF PUBLIC HEALTH POLICY (2020)

添加到收藏夹

Editorial Material Substance Abuse

Opioid Policy Changes During the COVID-19 Pandemic - and Beyond

Corey S. Davis et al.

JOURNAL OF ADDICTION MEDICINE (2020)

添加到收藏夹

Article Psychology

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply

Matthew Bonn et al.

Journal of Studies on Alcohol and Drugs (2020)

添加到收藏夹

Article Substance Abuse

Safer opioid distribution in response to the COVID-19 pandemic

Mark Tyndall

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

添加到收藏夹

Article Substance Abuse

Tackling the overdose crisis: The role of safe supply

Andrew Ivsins et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

添加到收藏夹

Article Medicine, General & Internal

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study

Vishal Sharma et al.

BMJ OPEN (2020)

添加到收藏夹

Article Substance Abuse

Stimulant safe supply: a potential opportunity to respond to the overdose epidemic

Taylor Fleming et al.

HARM REDUCTION JOURNAL (2020)

添加到收藏夹

Article Substance Abuse

Trajectories of retention in opioid agonist therapy in a Canadian setting

M. Eugenia Socias et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

添加到收藏夹

Review Medicine, General & Internal

Management of opioid use disorder in the USA: present status and future directions

Carlos Blanco et al.

LANCET (2019)

添加到收藏夹

Article Substance Abuse

Illicit fentanyls in the opioid street market: desired or imposed?

Sarah G. Mars et al.

ADDICTION (2019)

添加到收藏夹

Review Medicine, General & Internal

Management of opioid use disorders: a national clinical practice guideline

Julie Bruneau et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)

添加到收藏夹

Article Public, Environmental & Occupational Health

The opioid crisis in Canada: a national perspective

Lisa Belzak et al.

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE (2018)

添加到收藏夹

Article Substance Abuse

Consumer agency in cannabis supply - Exploring auto-regulatory documents of the cannabis social clubs in Spain

Vendula Belackova et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2018)

添加到收藏夹

Review Toxicology

Adverse effects of levamisole in cocaine users: a review and risk assessment

Tibor Markus Brunt et al.

ARCHIVES OF TOXICOLOGY (2017)

添加到收藏夹

Article Substance Abuse

Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay

Tom Decorte et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2017)

添加到收藏夹

Editorial Material Medicine, General & Internal

Flumazenil in benzodiazepine overdose

Howard An et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995

Yoko Murphy et al.

CLINICAL DRUG INVESTIGATION (2016)

添加到收藏夹

Review Clinical Neurology

Overview of four prescription monitoring/review programs in Canada

Andrea D. Furlan et al.

PAIN RESEARCH & MANAGEMENT (2014)

添加到收藏夹

Article Medicine, Legal

A Fatal Case of Benzodiazepine Withdrawal

Meredith A. Lann et al.

AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.